Market Research Logo

Global Sjogren’s Syndrome Therapeutics Market 2018-2022

Global Sjogren’s Syndrome Therapeutics Market 2018-2022

About Sjogren’s Syndrome

Sjogren’s syndrome is an autoimmune disorder and the major symptoms of this disorder are dry eyes and dry mouth. The mucous membranes produce reduced tears, and moisture-secreting glands in the mouth secrete smaller amounts of saliva.

Technavio’s analysts forecast the Global Sjogren’s Syndrome Therapeutics Market to grow at a CAGR of 4.12% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the sjogren’s syndrome therapeutics market. To calculate the market size, the report considers the revenue generated from the application of sjogren’s syndrome therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, sjogren’s syndrome therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • Biogen
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Novartis
Market driver
  • Strong pipeline
  • For a full, detailed list, view our report
Market challenge
  • Unwanted immunogenicity
  • For a full, detailed list, view our report
Market trend
  • Growing development of biologics
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Sjogren’s Syndrome Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global sjogren’s syndrome therapeutics market: Allergan, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche, and Novartis.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the growing development of biologics. Biologic drugs are being increasingly used as monotherapy or as a combination therapy for the treatment of sjogren’s syndrome.”

According to the report, one driver influencing this market is the strong pipeline. The number of molecules in the pipeline for the treatment of sjogren’s syndrome is increasing at a brisk pace which is expected to support the growth of the market.

Further, the report states that one challenge affecting this market is the unwanted immunogenicity. Immunogenicity is a major factor that can limit the growth of the global sjogren’s syndrome therapeutics market across the period of forecast.

Companies Mentioned

Allergan
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Novartis

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global immunology treatment market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global – Market size and forecast 2017-2022 ($ mn)
      • Table Global – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Drugs under development
      • Table Pipeline landscape for Sjogren's syndrome
      • Table Molecules in pipeline for treatment of Sjogren's syndrome 2017-2018
  • Market segmentation by subtype of syndrome
    • Segmentation by subtype of syndrome
      • Table Subtype of syndrome – Market share 2017-2022 (%)
    • Comparison by subtype of syndrome
      • Table Comparison by subtype of syndrome
    • Primary Sjogren's syndrome – Market size and forecast 2017-2022
      • Table Primary Sjogren's syndrome – Market size and forecast 2017-2022 ($ mn)
      • Table Primary Sjogren's syndrome – Year-over-year growth 2018-2022 (%)
    • Secondary Sjogren's syndrome – Market size and forecast 2017-2022
      • Table Secondary Sjogren's syndrome – Market size and forecast 2017-2022 ($ mn)
      • Table Secondary Sjogren's syndrome – Year-over-year growth 2018-2022 (%)
    • Market opportunity by subtype of syndrome
      • Table Market opportunity by subtype of syndrome
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Recently discontinued drugs
  • Market trends
    • Growing development of biologics
      • Table Development of biologics
    • Increasing diagnostic tests and biomarkers
    • Rising number of awareness programs
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN – Overview
      • Table ALLERGAN – Business segments
      • Table ALLERGAN – Organizational developments
      • Table ALLERGAN – Geographic focus
      • Table ALLERGAN – Segment focus
      • Table ALLERGAN – Key offerings
      • Table ALLERGAN – Key customers
    • Biogen
      • Table Biogen – Overview
      • Table Biogen – Business segments
      • Table Biogen – Organizational developments
      • Table Biogen – Geographic focus
      • Table Biogen – Key offerings
      • Table Biogen – Key customers
    • Bristol-Myers Squibb
      • Table Bristol-Myers Squibb – Overview
      • Table Bristol-Myers Squibb – Business segments
      • Table Bristol-Myers Squibb – Organizational developments
      • Table Bristol-Myers Squibb – Geographic focus
      • Table Bristol-Myers Squibb – Key offerings
      • Table Bristol-Myers Squibb – Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche – Overview
      • Table F. Hoffmann-La Roche – Business segments
      • Table F. Hoffmann-La Roche – Organizational developments
      • Table F. Hoffmann-La Roche – Geographic focus
      • Table F. Hoffmann-La Roche – Segment focus
      • Table F. Hoffmann-La Roche – Key offerings
      • Table F. Hoffmann-La Roche – Key customers
    • Novartis
      • Table Novartis – Overview
      • Table Novartis – Business segments
      • Table Novartis – Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis – Segment focus
      • Table Novartis – Key offerings
      • Table Novartis – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report